Larson Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Larson Financial Group's REGN Position: Q3 2026 in Review
Larson Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 17% in Q3 2026, buying an estimated $80.9K and bringing the position to 734 shares worth $556K. The position accounts for 0.01% of the portfolio, ranked #551.
Larson Financial Group first reported a position in REGN in Q4 2018 and has held it in 30 quarters since. 1,426 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Larson Financial Group held 734 shares of Regeneron Pharmaceuticals worth $556K as of Q3 2026.
- Larson Financial Group bought 107 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $80.9K.
- Regeneron Pharmaceuticals made up 0.01% of Larson Financial Group's portfolio in Q3 2026, its #551 holding.
- Larson Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 30 quarters since.
- 1,426 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.